22 completed, 15 recruiting, 12 unknown, 10 active not recruiting. 23 Not applicable, 21 Phase 1, 20 Phase 2, 5 Early Phase 1, 4 Phase 3.
Follow Pancreatic Carcinoma: new trials by email Literature Review of Pancreatic Carcinoma trials Research Report on Pancreatic Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Certepetide Phase 1b/2a Continuous Infusion Trial in mPDAC certepetide, nab-paclitaxel, gemcitabine - Pancreas Cancer, Pancreatic Carcinoma | Phase 1 / Phase 2 | Withdrawn | Lisata Therapeutics, Inc. | 2030-01-01 | 2025-06-06 | |
| Clinical Trial of DN022150 Combined With AG Chemotherapy as First-line Treatment for Locally Advanced or Metastatic Pancreatic Cancer With KRAS G12D Mutation DN022150+AG( Stage I ）, DN022150+AG（Stage II）, placebo+AG（Stage II） - Pancreatic Cancer, Pancreatic Carcinoma | Phase 2 / Phase 3 | Not yet recruiting | Jiangxi Kvvit Pharmaceutical Co., Ltd. | 465 | 2027-06-06 | 2026-06-18 |
| Evaluating the Effectiveness of AIT in the Treatment of Pain Related to Pancreatic Cancer Intrathecal catheter connected to an implantable pump, Administration of medication, including analgesics, via an intrathecal catheter connected to an implantable pump or via periodic injections - Pancreatic Cancer Pain, Intrathecal Analgesic | Not applicable | Not yet recruiting | Clinique Bizet | 40 | 2026-09-01 | 2026-09-10 |
| A Study of CLSP 5282 in HLA-A*03:01 Positive Adult Patients With Solid Tumors (SENTINEL-101) CLSP-5282 - Advanced Solid Tumor, Non Small Cell Lung Cancer | Phase 1 | Not yet recruiting | Clasp Therapeutics, Inc. | 140 | 2026-07-01 | 2026-06-16 |
| The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas Cancer Therapeutic Procedure, Questionnaire Administration - Amyloidosis, Basal Cell Carcinoma | Phase 2 | Recruiting | Mayo Clinic | 27 | 2025-12-18 | 2026-09-30 |
| Laryngopharyngeal Injury After Endotracheal Intubation Under General Anesthesia Gastric Cancer, Hepatic Carcinoma | Recruiting | Zhejiang University | 1200 | 2025-11-01 | 2026-01-22 | |
| Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers Computed Tomography, Fludeoxyglucose F-18, Gallium Ga 68 FAPi-46 - Anal Carcinoma, Bladder Carcinoma | Phase 1 | Active not recruiting | Jonsson Comprehensive Cancer Center | 30 | 2025-08-01 | 2026-10-20 |
| The Vanguard Study: Testing a New Way to Screen for Cancer Biospecimen Collection, Device Usage, Electronic Health Record Review - Bladder Carcinoma, Breast Carcinoma | Not applicable | Recruiting | National Cancer Institute (NCI) | 24000 | 2025-06-18 | 2026-10-06 |
| Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula Biospecimen Collection, Distal Pancreatectomy, Lanreotide - Pancreatic Carcinoma, Pancreatic Neoplasm | Phase 3 | Recruiting | SWOG Cancer Research Network | 274 | 2025-05-09 | 2026-03-31 |
| Mesothelin and Claudin 18.2 Dual-Target CAR-T Therapy in Advanced Pancreatic Cancer Mesothelin and Claudin 18.2 CAR-T cells - Pancreatic Cancer, Pancreatic Carcinoma | Phase 1 / Phase 2 | Recruiting | Essen Biotech | 60 | 2025-04-29 | 2025-07-15 |
| A Study of MGC028 in Participants With Advanced Solid Tumors MGC028 - Advanced Solid Tumors, NSCLC Adenocarcinoma | Phase 1 | Recruiting | MacroGenics | 124 | 2025-02-13 | 2026-04-27 |
| Personalized Education and Genetic Counseling to Increase Genetic Testing in Patients With a Known Family History of Pancreatic Cancer Biospecimen Collection, Educational Intervention, Electronic Health Record Review - Pancreatic Carcinoma | Not applicable | Enrolling by invitation | Mayo Clinic | 50 | 2025-02-12 | 2026-06-04 |
| Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts Non-Interventional Study - Pancreatic Carcinoma | Recruiting | Mayo Clinic | 30000 | 2024-12-12 | 2026-09-21 | |
| Effects of Aromatherapy With Essential Oils on Anxiety and Depression in Perioperative Patients With Pancreatic Cancer Experimental: Aromatherapy with essential oil intervention, Control Group 0.9% Isotonic Saline - Pancreatic Carcinoma | Not applicable | Completed | Peking University First Hospital | 156 | 2024-09-01 | 2026-09-28 |
| CEB-01 in Locally Resectable Pancreatic Cancer Standard surgery, CEB-01 - Pancreatic Carcinoma | Early Phase 1 | Active not recruiting | CEBIOTEX | 39 | 2024-08-20 | 2026-10-14 |
| The PLATINUM Trial: Optimizing Chemotherapy for the Second-Line Treatment of Metastatic BRCA1/2 or PALB2-Associated Metastatic Pancreatic Cancer Nab paclitaxel, Gemcitabine, Cisplatin - Pancreatic Acinar Cell Carcinoma, Pancreatic Adenocarcinoma | Phase 2 / Phase 3 | Active not recruiting | Alliance for Clinical Trials in Oncology | 10 | 2024-08-13 | 2026-10-19 |
| Use Of Indocyanine Green In Pancreas Surgery Non-Interventional Study - Pancreatic Carcinoma | Recruiting | OHSU Knight Cancer Institute | 55 | 2024-02-29 | 2026-08-31 | |
| A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors HER3-DXd - Advanced Solid Tumor, Melanoma | Phase 2 | Recruiting | Daiichi Sankyo | 740 | 2024-02-26 | 2026-10-01 |
| Binimetinib and Palbociclib Before Surgery for the Treatment of Operable KRAS-Positive Lung, Colorectal, or Pancreatic Cancer Binimetinib, Palbociclib, Therapeutic Conventional Surgery - Colorectal Carcinoma, Lung Adenocarcinoma | Early Phase 1 | Withdrawn | Roswell Park Cancer Institute | 2024-01-15 | 2023-12-22 | |
| In This Study, a Retrospective Analysis Was Conducted to Explore the Risk Factors for Patients Undergoing Pancreaticoduodenal Surgery (PD) to Achieve TO, and a Nomogram Prediction Model Was Further Established to Promote the Standardization and Standardization of PD Surgical Quality Evaluation. Pancreatic Carcinoma, Cholangiocarcinoma | Unknown | luokai zhang | 280 | 2024-01-01 | 2025-01-08 |
Showing 20 of 75. Sign in to see all of them.
Pancreatic Neoplasms (75) · Carcinoma, Hepatocellular (16) · Colorectal Neoplasms (15) · Breast Neoplasms (13) · Ovarian Neoplasms (13) · Stomach Neoplasms (13) · Prostatic Neoplasms (12) · Lung Neoplasms (11) · Carcinoma, Non-Small-Cell Lung (10) · Melanoma (9) · Carcinoma, Renal Cell (8) · Endometrial Neoplasms (8) · Cholangiocarcinoma (7) · Esophageal Neoplasms (7) · Urinary Bladder Neoplasms (7)
Digestive System Diseases (75) · Digestive System Neoplasms (75) · Endocrine Gland Neoplasms (75) · Endocrine System Diseases (75) · Neoplasms by Site (75) · Pancreatic Diseases (75) · Neoplasms (73) · Neoplasms by Histologic Type (29) · Neoplasms, Glandular and Epithelial (27) · Gastrointestinal Diseases (26) · Adenocarcinoma (25) · Carcinoma (25) · Gastrointestinal Neoplasms (23) · Intestinal Diseases (22) · Intestinal Neoplasms (22)
Gemcitabine (7) · Magnetic Resonance Spectroscopy (4) · Heavy Ion Radiotherapy (3) · Practice Guidelines as Topic (3) · Specimen Handling (3) · Standard of Care (3) · Taxes (3) · pembrolizumab (3) · AM0010 (2) · Albumin-Bound Paclitaxel (2) · Cisplatin (2) · Control Groups (2) · Early Intervention, Educational (2) · Educational Status (2) · FAPI-46 (2)
City of Hope Medical Center (4) · Mayo Clinic (3) · Memorial Sloan Kettering Cancer Center (3) · Shanghai Proton and Heavy Ion Center (3) · BioNTech Research & Development, Inc. (2) · Eli Lilly and Company (2) · Jonsson Comprehensive Cancer Center (2) · National Cancer Institute (NCI) (2) · OHSU Knight Cancer Institute (2) · Ohio State University Comprehensive Cancer Center (2) · Peking Union Medical College Hospital (2) · PersonGen BioTherapeutics (Suzhou) Co., Ltd. (2) · The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School (2) · University of Southern California (2) · Xencor, Inc. (2)
United States (44) · China (24) · France (5) · Germany (4) · Japan (4) · Belgium (3) · Italy (3) · South Korea (3) · Spain (3) · Australia (2) · Hong Kong (2) · United Kingdom (2) · Canada (1) · Finland (1) · Hungary (1)
Lin Yang, Ph.D. (2) · Adrianna D. Clapp, MD (1) · Aiming Yang, M.D. (1) · Ajay Goel, PhD (1) · Andrei Iagaru (1) · Ann L. Oberg, PhD (1) · Avi Retter, M.D. (1) · Azeez Farooki, MD (1) · Benjamin Thompson, MD, PhD (1) · Brett C Sheppard, M.D., FACS (1) · Chet Bohac, MD, MSc (1) · Chi Cao, MD (1) · Ching-Wei D Tzeng (1)
PMID 35046060, PMID 10488677, PMID 10642496, PMID 14612485, PMID 18054150, PMID 18443642, PMID 25638694, PMID 27528724, PMID 28025375, PMID 28054442, PMID 28143873, PMID 28978306, PMID 29543644, PMID 29852194, PMID 30660818, PMID 31563517, PMID 31845007, PMID 33433743, PMID 33605677, PMID 34132691, PMID 34484187, PMID 34729628, PMID 34935483, PMID 35183448, PMID 35379633, PMID 35850192, PMID 36512649, PMID 37878305, PMID 38721402, PMID 40087747, PMID 40554527, PMID 41088723, PMID 41101974, PMID 41121171, PMID 41128852, PMID 41166694, PMID 41324566, PMID 41951900, PMID 42129445, PMID 42217668, PMID 42571808, PMID 42749887
P30CA015704 (3), P30CA014089 (2), 2014 (1), 2016 (1), 2023 (1), P30CA033572 (1), P30CA047904 (1), P30CA093373 (1), P30CA124435 (1), U01CA062505 (1), U01CA099168 (1), U01CA132194 (1), U01CA210138 (1), U24CA274496 (1), UG1CA189974 (1)